Kindlin-2-Moesin interaction orchestrates sprouting angiogenesis via modulating endothelial membrane mechanics and VEGF signaling

This study reveals that the Kindlin-2-Moesin interaction regulates sprouting angiogenesis by maintaining optimal endothelial membrane tension to facilitate VEGFR2 endocytosis and signaling, offering a potential therapeutic target for neovascular diseases.

The Gist

Imagine your body's blood vessels as a bustling city's road network. For this city to grow, heal, or repair itself, it needs to build new roads (a process called angiogenesis). This construction is directed by a foreman named VEGF (Vascular Endothelial Growth Factor), who shouts orders to the construction crews (endothelial cells) to start building.

But here's the catch: the construction crews can't just listen to the foreman; they also need to feel the ground beneath their feet. If the ground is too loose or too tight, they can't build properly.

This paper discovers a fascinating new rule in how this construction happens. It involves two key characters: Kindlin-2 and Moesin.

The Characters

1. Kindlin-2: Think of this as the Site Manager. It's a protein that is always present in the blood vessel cells, making sure everything runs smoothly.
2. Moesin: Think of this as the Tension Wire. It connects the cell's outer skin (the membrane) to its internal skeleton (the actin cortex). It controls how "tight" or "loose" the cell's skin is.
3. VEGFR2: This is the Foreman's Megaphone on the cell surface. It receives the "Build!" signal from VEGF.

The Problem: A Tangled Wire

In a healthy cell, the Site Manager (Kindlin-2) has a special job: it gently holds onto the Tension Wire (Moesin) to keep it from getting too excited.

• The Analogy: Imagine Moesin is a rubber band. If you stretch it too much, it snaps or pulls the whole structure apart. Kindlin-2 acts like a hand that gently grips the rubber band, keeping the tension just right—tight enough to hold shape, but loose enough to move.

The Discovery: What Happens When the Manager is Gone?

The researchers removed the Site Manager (Kindlin-2) from the blood vessel cells. Here is what went wrong:

1. The Rubber Band Snaps Tight: Without Kindlin-2 to hold it back, the Tension Wire (Moesin) went into overdrive. It pulled the cell's skin too tight.
2. The Door Won't Open: To get the "Build!" signal inside the cell, the megaphone (VEGFR2) needs to be pulled inside the cell (a process called endocytosis). Think of this like a delivery truck needing to drive through a gate.
   • Because the cell skin was pulled too tight by the overactive Moesin, the "gate" became too stiff to open.
   • The delivery truck (VEGFR2) couldn't get inside.
3. Construction Stops: Since the signal couldn't get inside, the cell didn't know it was time to build. The blood vessels stopped growing, and the tips of the new vessels looked like blunt, broken sticks instead of sharp, exploring fingers.

The "Magic" Connection

The scientists found that Kindlin-2 and Moesin hold hands at a very specific spot: a tiny hook on Moesin called N62.

• When they hold hands, the tension is perfect, and the gates open smoothly.
• When they don't hold hands (either because Kindlin-2 is missing or because the N62 hook is broken), the tension goes haywire, and the blood vessels fail to grow.

Why Does This Matter?

This discovery is like finding a new switch for a light dimmer.

• In Development: It explains how our bodies know exactly how much blood vessel to grow when we are babies.
• In Disease: Many diseases, like diabetic retinopathy (which causes blindness) or cancer, involve blood vessels growing too much and chaotically.
  • The paper shows that in these disease states, the Kindlin-2 and Moesin "handshake" gets stronger, which might be part of the problem.
  • The Solution: If we can design a drug that stops them from holding hands (specifically at that N62 spot), we might be able to calm down the overactive blood vessels in diseases without hurting the healthy ones.

The Bottom Line

This paper tells us that building blood vessels isn't just about chemical signals; it's also about physical mechanics. The cell needs to feel the right amount of "tightness" on its skin to hear the instructions to grow. Kindlin-2 is the gentle hand that keeps that tension perfect, ensuring our vascular city gets built correctly.

Technical Summary

1. Problem Statement

While the role of extracellular mechanical forces (e.g., shear stress, matrix stiffness) in vascular development is well-established, the mechanisms by which cell-intrinsic membrane mechanics regulate sprouting angiogenesis remain poorly understood. Specifically, it is unclear how endothelial cells (ECs) integrate mechanical cues with molecular signaling pathways, such as VEGF signaling, to drive the formation of new blood vessels. The study seeks to identify the molecular regulators of endothelial membrane tension and elucidate their impact on angiogenic sprouting.

2. Methodology

The authors employed a multidisciplinary approach combining in vivo mouse models, ex vivo assays, and in vitro cell biology techniques:

• Genetic Models:
  • Generated endothelial-specific inducible knockout mice for Kindlin-2 (Kindlin-2^iΔEC(Pdgfb) and Kindlin-2^iΔEC(Cdh5)) and Integrin β1 (Itgb1^iΔEC(Pdgfb)) to study developmental angiogenesis (retina and brain) and pathological angiogenesis (OIR and CNV models).
  • Used Tamoxifen induction to delete genes at specific developmental stages (e.g., P1–P3 for retinal angiogenesis, P12–P14 for pathological neovascularization).
• Protein Interaction Mapping:
  • Mass Spectrometry (IP-MS): Identified Moesin as a primary binding partner of Kindlin-2 in HUVECs.
  • Co-Immunoprecipitation (Co-IP) & Split-GFP: Validated the interaction and mapped the binding domains (Kindlin-2 N-terminus and Moesin N-terminus).
  • AlphaFold & Mutagenesis: Predicted the binding interface and generated the Moesin^N62A point mutation to disrupt binding.
  • Proximity Ligation Assay (PLA): Visualized endogenous Kindlin-2–Moesin interactions in tissue sections.
• Membrane Mechanics Assessment:
  • MSS Biosensor: A FRET-based membrane tension sensor to measure tension changes.
  • Flipper-TR: A fluorescent lipid tension reporter measured via Fluorescence Lifetime Imaging Microscopy (FLIM).
  • Hypotonic Treatment: Used to artificially increase membrane tension as a control.
• Signaling & Functional Assays:
  • VEGFR2 Endocytosis: Measured via Alexa 594-labeled VEGF uptake, cell surface biotinylation assays, and intracellular VEGFR2 staining.
  • Downstream Signaling: Western blotting for p-ERK levels.
  • Angiogenic Phenotypes: Retinal flat-mounts, aortic ring assays, bead sprouting assays, and filopodia formation assays.
  • Pathological Models: Oxygen-Induced Retinopathy (OIR) and Laser-Induced Choroidal Neovascularization (CNV).
  • Rescue Experiments: Used siRNA knockdown of Moesin (MSN) and AAV-mediated delivery to test if Moesin depletion rescues Kindlin-2 deficiency phenotypes.

3. Key Contributions

• Discovery of a Novel Mechanism: Identified Kindlin-2 as a critical regulator of sprouting angiogenesis that functions independently of its canonical role in Integrin activation.
• Kindlin-2–Moesin Axis: Uncovered a direct physical interaction between Kindlin-2 and Moesin (an ERM family protein) at the N62 residue of Moesin.
• Mechanotransduction Link: Demonstrated that this interaction regulates membrane tension. Kindlin-2 binding prevents Moesin overactivation (hyper-phosphorylation), thereby maintaining optimal membrane tension required for receptor endocytosis.
• VEGFR2 Regulation: Established that membrane tension, controlled by the Kindlin-2–Moesin axis, is a prerequisite for efficient VEGFR2 endocytosis and subsequent ERK signaling.

4. Key Results

A. Endothelial Kindlin-2 is Essential for Sprouting Angiogenesis

• Deletion of Kindlin-2 in ECs (Kindlin-2^iΔEC) caused severe vascular defects: reduced vascular coverage, fewer branch points, and impaired deep vascular plexus formation in the retina and brain.
• Tip Cell Phenotype: Tip cells in Kindlin-2-deficient retinas exhibited a "blunted, aneurysm-like" structure with dysmorphic filopodia, indicating a failure in sprouting initiation.
• Distinct from Integrin β1: Unlike Integrin β1 knockout (which reduced radial outgrowth but preserved tip cell sprouting), Kindlin-2 loss specifically impaired tip cell morphology and sprouting, suggesting a non-integrin-mediated mechanism.

B. Kindlin-2 Binds Moesin to Regulate Membrane Tension

• Interaction: Kindlin-2 binds directly to Moesin via the N62 residue of Moesin.
• Regulation of Activation: In the absence of Kindlin-2, Moesin becomes hyper-phosphorylated (p-ERM levels increase), leading to excessive membrane-cortex attachment.
• Membrane Tension: Both Kindlin-2 knockdown and expression of constitutively active Moesin (Moesin^T558D) resulted in increased membrane tension (measured by MSS and Flipper-TR).
• Rescue: Co-knockdown of Moesin in Kindlin-2-deficient cells restored membrane tension to normal levels.

C. Membrane Tension Controls VEGFR2 Endocytosis

• Endocytosis Defect: High membrane tension (caused by Kindlin-2 loss or Moesin^T558D expression) significantly impaired VEGFR2 internalization.
• Signaling Consequence: Reduced VEGFR2 endocytosis led to diminished VEGF-induced ERK phosphorylation, blunting the angiogenic signal.
• Mechanism: The study posits that proper membrane tension is required for the membrane curvature changes necessary for VEGFR2 endocytosis.

D. Pathological Relevance

• OIR Model: In the oxygen-induced retinopathy model (mimicking ROP/PDR), Kindlin-2 deletion significantly reduced pathological neovascular tufts.
• CNV Model: In the laser-induced choroidal neovascularization model (mimicking nvAMD), Kindlin-2 deletion reduced CNV volume.
• Therapeutic Potential: The Moesin^N62A mutant (which cannot bind Kindlin-2) phenocopied the Kindlin-2 loss, confirming that disrupting this specific interface inhibits pathological angiogenesis.

5. Significance

• Mechanobiology of Angiogenesis: This study provides a crucial mechanistic link between cell-intrinsic membrane mechanics and growth factor signaling. It reveals that membrane tension is not just a passive physical property but an active regulator of receptor trafficking and signal transduction.
• New Therapeutic Target: The identification of the Kindlin-2–Moesin N62 interaction offers a novel therapeutic target for neovascular diseases (e.g., diabetic retinopathy, AMD, cancer). Targeting this specific interface could inhibit pathological angiogenesis without necessarily blocking integrin-mediated adhesion, potentially avoiding the side effects associated with broad integrin inhibition.
• Paradigm Shift: It challenges the view that Kindlin-2 functions solely through Integrins, highlighting its role as a mechano-regulator of the actin cortex and membrane dynamics in endothelial cells.